Mechanical factors |
Miniaturized CPB circuit |
Decrease contact activation, decreased hemodilution |
Coated CPB circuit (heparin, PMEA) |
Decrease contact activation |
Leukocyte filtration |
Remove activated leukocytes, especially for longer CPB duration |
Retrograde autologous priming (RAP) |
Decrease hemodilution |
Ultrafiltration (modified, zero-balance) |
Hemoconcentration, filtration of mediators |
Normoxia on CPB |
Reduce reperfusion injury with free oxygen radicals |
Surgical technique |
Avoid CPB if possible |
|
Reduce the duration of time on CPB |
Reduction in time available for inflammation/ischemic injury to lungs |
Cardioprotection with cardioplegia |
Prevent ischemia–reperfusion injury |
Minimize cardiotomy suction |
Decrease blood–air contact; decrease activation of inflammatory response |
Transfusion-sparing techniques |
Decrease inflammation/immune responses to transfusion |
Partial lung perfusion |
Decrease ischemia to lungs, more complicated surgical procedure |
Anesthesia factors |
Intermittent ventilation |
Prevent atelectasis |
Recruitment maneuver |
Reduce atelectasis, improve respiratory mechanics, reduce volutrauma |
Low tidal volume ventilation |
Prevent shear stress, various types of trauma to lungs: volutrauma, barotraumas, and atelectatrauma |
Volatile anesthesia-based |
|
Medications |
Steroids |
Modulate immune response, potential negative impact on glucose control and wound healing |
Neutrophil elastase inhibitors |
Inhibit neutrophil elastase and reduce leukocyte sequestration in the lungs |
Hypertonic saline |
Decrease extravascular lung water, improve oxygenation |
Aprotonin |
Decrease extravascular lung water, improve oxygenation, and reduce neutrophil sequestration |